Our Team

We are a creative, focused team with high scientific standards
We are scientists and engineers driven to make drug development a true design discipline. Our culture prizes speed, creativity, and rigor: we debate ideas with data, not ego; we value steep growth over static titles; and we work in-person, shoulder-to-shoulder in the lab every day. If you thrive on hard problems and want your work to matter for patients, this is where to build.
















Latest News
De novo design of antibodies enabled by Joint Atomic Modeling
Nabla Bio Moves Closer to AI Created Antibodies
Nabla Bio Secures $26M Series A Financing and Collaborations with AstraZeneca, Bristol Myers Squibb and Takeda for Generative Protein Design
Harvard startup raises $26M, strikes three pharma partnerships for AI antibody design
Harvard spinout Nabla Bio nabs $11M for AI-driven antibody design
Nabla Bio Closes $11M Seed Financing led by Khosla Ventures and Zetta Venture Partners